Johnson & Johnson announced the global launch of its Shockwave C2 Aero Coronary IVL Catheter designed for improved deliverability, enhanced lesion crossing and new repositioning capabilities for the treatment of calcified coronary artery disease. The next-generation coronary IVL catheter leverages Shockwave IVL’s mechanism of action and the safety and effectiveness profile of its legacy catheters, expanding the company’s IVL portfolio. Shockwave C2 Aero is now available in the United States and Japan and will be available in Europe and Canada in the coming months.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on JNJ:
- Kennedy driving vast vaccine inquiry despite toned-down criticism, NYT says
- Looking Beyond VOO? These 3 BlackRock ETFs Offer 20%+ Upside in 2026
- Psychedelic: Jefferies initiates Compass Pathways with a Buy rating
- Best ETFs to Invest In, According to AI Analyst, 5/6/2026
- FDA blocked publication of studies showing Covid vaccine safe, NYT says